Form 4 for RLAY Relay Therapeutics, Inc.
Accepted 2024-07-01 00:00:00 ET · period of report 2024-06-27 · accession 0000950170-24-079691 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-01 | 2024-06-27 | RLAY | Rahmer Peter | See remarks | S - Sale | $6.26 | -245 | 432.2K | -0.1% | -$1,534 | |
| 2024-07-01 | 2024-06-30 | RLAY | Rahmer Peter | See remarks | A - Grant | $5.54 | +2,108 | 434.3K | +0.5% | +$11.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-27 | S | D | 245 | $6.26 | 432,180 | D | — | — | (F1) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on June 26, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F2) Includes 383,442 shares underlying RSUs. |
| 2 | Common | Common Stock | 2024-06-30 | A | A | 2,108 | $5.54 | 434,288 | D | — | — | (F4) In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 28, 2024. (F2) Includes 383,442 shares underlying RSUs. |